Pharmafile Logo
Pharmafocus logo
Advanced Search

8 out of 10 pharmaceutical companies say developing Covid tests and vaccines has impacted their development pipeline

February 23, 2023
Business Services

LONDON 23rd February 2023 

News
Press release

BiomX shares positive data from first bacteriophage trial

February 23, 2023
Research and Development

BiomX has shared data from a new study in cystic fibrosis (CF) patients, assessing whether bacteriophages could be a new …

News

Redx Pharma agrees to $425m all-share merger with Jounce Therapeutics

February 23, 2023
Research and Development

UK-based clinical-stage biotech company Redx Pharma has agreed to a $425m all-share merger with US drug research business Jounce Therapeutics. …

News

AstraZeneca signs $63m agreement for gastric cancer treatment

February 23, 2023
Medical Communications

AstraZeneca has announced that it has signed an exclusive license agreement (ELA) with KYM Biosciences Inc for CMG901, which is …

News

£1.6bn of research and development funding “surrendered” back to UK Treasury

February 23, 2023
Medical Communications

A pot of £1.6bn which was originally allocated as the UK’s contribution to the €96bn Horizon Europe research funding programme …

News

OSE Immunotherapeutics Updates on Anti-IL-7 Receptor Antagonist OSE-127/S95011, a Breakthrough Approach in Chronic Inflammatory Autoimmune Diseases and Hematology

February 22, 2023
Business Services

Nantes, France – February 22, 2023, 6:00 p.m.

News
Press release

Karyopharm and Menarini gain full MHRA approval for multiple myeloma drug

February 22, 2023
Research and Development

Pharmaceutical companies Karyopharm Therapeutics and Menarini Group have announced that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) have …

News

FDA grants approval to Beckley Psytech’s short-acting psychedelic trial

February 22, 2023
Research and Development

Beckley Psytech, a private, clinical-stage biotech company, announced that the FDA has granted Investigational New Drug (IND) approval for their …

News

ViiV Healthcare receives EU Marketing Authorisation for Triumeq PD, the first dispersible single tablet regimen containing dolutegravir, a once-daily treatment for children living with HIV in Europe

February 22, 2023
Business Services

  

News
Press release

PHARMANOVIA ENTERS IN-LICENSING AGREEMENT WITH AXSOME THERAPEUTICS TO MARKET AND FURTHER DEVELOP SUNOSI® (SOLRIAMFETOL), A FIRST-IN-CLASS TREATMENT FOR EXCESSIVE DAYTIME SLEEPINESS (EDS) IN PEOPLE WITH NARCOLEPSY AND OBSTRUCTIVE SLEEP APNOEA

February 22, 2023
Business Services

BASILDON, UK, 22 February 2023   Pharmanovia, a global pharmaceutical company that revitalises, extends and expands the lifecycle of already …

News
Press release

Relation Therapeutics announces launch of flagship integrated wet–dry laboratory at the heart of London’s Knowledge Quarter

February 22, 2023
Business Services

London, February 22, 2023 – Relation Therapeutics, a leader in the use of high-resolution biology, machine learning and clinical insights …

News
Press release

NICE Publishes Reimbursement Recommendation for Translarna™

February 22, 2023
Business Services

London, UK, 22nd February, 2023 — PTC Therapeutics, Ltd. today announced the National Institute for Health and Care Excellence (NICE) has published …

News
Press release

Indegene launches Metaverse capabilities to help life sciences companies create immersive healthcare experiences

February 22, 2023
Business Services

Princeton, United States / Bengaluru, India, February 21, 2023: Indegene, a digital-first, life sciences commercialization company today announced the launch …

News
Press release

Modus Therapeutics announces positive topline data from its Phase 1b LPS provocation study evaluating the potential of sevuparin for treatment of sepsis

February 22, 2023
Business Services

STOCKHOLM, SWEDEN – 21 February 2023: Modus Therapeutics AB (“Modus”), a company developing innovative treatments for patients with major unmet …

News
Press release

FDA approval granted to BD’s HPV assay for use with ThinPrep Pap Test

February 22, 2023
Medical Communications

Becton, Dickinson and Company (BD) has received FDA approval for its new HPV assay which will be used in testing …

News

Pfizer likely to be first to gain FDA approval for new RSV vaccine

February 22, 2023
Research and Development

The FDA is expected to approve Pfizer’s new respiratory syncytial virus (RSV) vaccine this summer following its acceptance of the …

News

Beckley Psytech receives FDA Investigational New Drug (IND) approval for Phase IIb study of BPL-003, a novel synthetic formulation of 5-MeO-DMT (Mebufotenin)

February 21, 2023
Business Services

Oxford, United Kingdom – 21 FEBRUARY 2023 – Beckley Psytech Ltd, a private, clinical-stage biotechnology company dedicated to addressing neuropsychiatric …

News
Press release

Unum UK expands employee digital health app

February 21, 2023
Medical Communications

Employee benefits provider Unum UK has expanded its available modules on its Help@hand app, which aims to provide digital health …

News

CSL receives CMA from the European Commission for haemophilia B drug

February 21, 2023
Medical Communications

CSL, a biotech company, has announced that it has received conditional marketing authorisation (CMA) from the European Commission (EC) for …

News

Hemab secures $135m in Series B funding for rare bleeding disorder treatment

February 21, 2023
Research and Development

Hemab Therapeutics announced it received $135m from their oversubscribed Series B funding round. The funding will be used for their …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026